Coronavirus News LIVE Updates: The Serum Institute of India became the first indigenous company on Sunday to apply to the Controller General of Drugs of India (DCGI) seeking an emergency use authorization for Oxford COVID-19
vaccine in the country citing unmet medical needs due to the pandemic and in the interest of the general public, official sources said. A day earlier, the Indian arm of the American pharmaceutical giant Pfizer became the first to apply for similar approval from the Indian drug regulator for its own COVID-19 vaccine in the country, after obtaining such authorization in the United Kingdom and Bahrain. The Oxford Phase Three Clinical Trial COVID-19 The vaccine, Covishield, is being made by the Pune-based Serum Institute of India on Sunday (SII), co-sponsored by the Indian Council for Medical Research (ICMR), in various parts of the country, in addition to the clinical studies it is conducting. carried out Oxford-AstraZeneca in the UK and Brazil. Based on the results of phase two and three clinical trials, IBS, with the help of ICMR, will seek early availability of the vaccine for India, the country’s lead health research body said last month.
Here are the latest updates on coronavirus:
• According to ICMR, SII has already manufactured 40 million doses of the vaccine under the manufacturing and storage-at-risk license obtained from DCGI. Official sources, citing the IBS request, said the firm has stated that data from four clinical studies, two in the UK and one in Brazil and India, show that Covishield is highly effective against symptomatic symptoms and, most importantly, against grave COVID-19 Infections Results are in line with other coronavirus vaccines and due to the huge disease burden, Covishield is expected to provide substantial relief COVID-19 mortality and morbidity, the company was known to have said.
• Donald Trump said Sunday that his personal attorney Rudy Giuliani tested positive for COVID-19, the last member of the president’s inner circle, where the use of masks is rare, contracted the disease. Giuliani’s diagnosis comes after he has been touring the country, leading the president’s defiant – and unsuccessful – effort to undo Joe Biden’s victory in the November 3 presidential election.
• An indicator of Asian equities hit a record high on Monday in hopes of a much-needed US stimulus package before the end of the year as well as coronavirus vaccines are launched, while oil prices are approaching their highest level since March. Japan’s Nikkei added 0.1%, while Australia’s shares rose 0.8%.
• Sinovac Biotech of China has obtained $ 515 million in financing from a local company to double the production capacity of its coronavirus vaccine, the companies said Monday, as they expect efficacy data from its experimental injection this month. The investment agreement also comes as Sinovac expands supply agreements and testing of its COVID-19 CoronaVac vaccine with more countries following positive results from early to mid-stage clinical trials.
• With a COVID-19 Perhaps just days away from the vaccine in the U.S., most of California headed for another lockdown Sunday due to the growing outbreak and top health officials warned Americans that this is not the time to lower the guard. “Vaccine is critical,” Dr. Deborah Birx, White House coronavirus Response coordinator said on NBC’s “Meet the Press.” “But it is not going to save us from this current increase. Only we can save ourselves from this current increase. “
.
